Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Morning Bell 26 July

Sophia Mavridis
July 26, 2022

Morning Bell 25 July

Sophia Mavridis
July 25, 2022

Weekly Wrap 22 July

Sophia Mavridis
July 22, 2022

Morning Bell 21 July

Paulina Peters
July 21, 2022

Morning Bell 20 July

Sophia Mavridis
July 20, 2022

Morning Bell 19 July

Paulina Peters
July 19, 2022

Morning Bell 18 July

Sophia Mavridis
July 18, 2022

Weekly Wrap 15 July

Sophia Mavridis
July 15, 2022

Morning Bell 14 July

Paulina Peters
July 14, 2022

Morning Bell 13 July

Sophia Mavridis
July 13, 2022

Morning Bell 12 July

Paulina Peters
July 12, 2022

Morning Bell 11 July

Sophia Mavridis
July 11, 2022